Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients

Epstein-Barr virus (EBV) has been used as a paradigm for studying host–virus interactions, not only because of its importance as a human oncogenic virus associated with several malignancies including nasopharyngeal carcinoma (NPC) but also owing to its sophisticated strategies to subvert the host an...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yong, Zhang, Suzhan, Sun, Ren, Wu, Tingting, Qian, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395660/
https://www.ncbi.nlm.nih.gov/pubmed/26038769
http://dx.doi.org/10.1038/emi.2015.20
Descripción
Sumario:Epstein-Barr virus (EBV) has been used as a paradigm for studying host–virus interactions, not only because of its importance as a human oncogenic virus associated with several malignancies including nasopharyngeal carcinoma (NPC) but also owing to its sophisticated strategies to subvert the host antiviral responses. An understanding of the interplay between EBV and NPC is critical for the development of EBV-targeted immunotherapy. Here, we summarize the current knowledge regarding the host immune responses and EBV immune evasion mechanisms in the context of NPC.

Ejemplares similares